GGrantIndex
Sort

64,565 grants matching drug discovery

RP2: Targeting genes and pathways for autophagy-dependent inhibition of bacterial infection

$1,480,332
Ramnik J Xavier · Ut Southwestern Medical Center · U19 · FY2019 · AI

Drug Development for Alzheimer's neuroinflammation

$1,480,275
Hussein N Yassine · University Of Southern California · U01 · FY2025 · AG

Investigations of Methylmalonic Acidemia and Related Disorders

$1,480,072
Charles P Venditti · National Human Genome Research Institute · ZIA · FY2012 · HG

CORAL CENTER

$1,479,814
Natalie Dolores Hernandez · Morehouse School Of Medicine · U54 · FY2025 · HD

ARMOR Trial

$1,479,702
Patricia M Corby · University Of Pennsylvania · U01 · FY2019 · DE

BIOLOGICAL TESTING FACILITY - DISCOVERY, CLINICAL FORMULATION, AND MANUFACTURE OF CONTRACEPTIVES

$1,479,511
Deborah Bunin · Sri International · N01 · FY2024 · HD

MCSP TORFP NO. NIH-NINDS-20-03: KATRITCH (USC) - BASE EC (PAIN)

$1,479,377
Keith Barnes · Albany Molecular Research, Inc. · N01 · FY2022 · DA

Center for Biomolecular NMR Data Processing and Analysis

$1,479,145
Jeffrey C Hoch · University Of Connecticut Sch Of Med/Dnt · P41 · FY2020 · GM

New therapies for liver fibrosis and hyperproliferation in alpha1-AT deficiency

$1,479,015
David H Perlmutter · Washington University · P01 · FY2016 · DK

SPORE in Prostate Cancer

$1,478,967
Samuel R Denmeade · Johns Hopkins University · P50 · FY2020 · CA

Clark Atlanta University Biomedical Science Development

$1,477,867
Carlton E. Brown · Clark Atlanta University · G12 · FY2011 · RR

UCLA CENTER FOR DIETARY SUPPLEMENTS RESEARCH: BOTANICALS

$1,477,159
University Of California Los Angeles · P50 · FY2003 · AT

Establishing a Gram-Negative Permeation Rule Set Leveraging a Unique Small Molecule Library

$1,477,022
Steven Armen Boyd · Venatorx Pharmaceuticals, Inc. · R01 · FY2022 · AI

Endocannabinoid Active Sites as Therapeutic Targets

$1,477,010
Alexandros Makriyannis · Northeastern University · P01 · FY2022 · DA

MCSP TORFP NO. NIH-NINDS-21-01: FLORIO (ANAGIN) - BASE EC (STROKE)

$1,476,441
Melissa Allard · Albany Molecular Research, Inc. · N01 · FY2023 · DA

Clinical Studies of the Molecular Genetic Basis of Kidney Cancer

$1,476,414
William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Research Capacity Core

$1,476,352
Yanyuan Wu · Charles R. Drew University Of Med & Sci · U54 · FY2025 · MD

Algorithms and Software for Biomolecular Structure Determination at the Proteome Scale

$1,476,000
Ellen Dee Zhong · Princeton University · DP2 · FY2025 · GM

Targeting Remyelination to Treat Preterm Brain Injury

$1,476,000
Bridget Lamonica Ostrem · University Of California, San Francisco · DP2 · FY2025 · NS

Mapping polymicrobial interactions that modulate antibiotic persistence

$1,476,000
Wendy W.k. Mok · University Of Connecticut Sch Of Med/Dnt · DP2 · FY2021 · GM

Targeting tau for the development of novel Alzheimer's disease therapeutics

$1,475,961
Glenn Larsen · Aquinnah Pharmaceuticals, Inc. · R44 · FY2020 · AG

Genetic Neurobiology Of Drosophila

$1,475,821
Howard A Nash · National Institute Of Mental Health · ZIA · FY2010 · MH

Preclinical development of a novel small molecule inhibitor of Alzheimer's disease-related cognitive impairment

$1,475,773
D. Martin Watterson · Northwestern University At Chicago · U01 · FY2020 · AG

CATHEPSIN L INHIBITORS AS PAN-CORONAVIRUS THERAPEUTICS

$1,475,511
Doron Greenbaum · Phelix Therapeutics, Llc · R44 · FY2015 · AI

Interdisciplinary Center for Male Contraceptive Research and Drug Development

$1,475,254
Joseph S Tash · University Of Kansas Medical Center · U54 · FY2008 · HD